Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CD74-ROS1 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD74-ROS1 fusion	Non Small Cell Lung Cancer	CD74-ROS1 fusion	Non Small Cell Lung Cancer	AB-106 Sensitive: C2 – Inclusion Criteria AB-106 Sensitive : C2	AB-106 Sensitive: C2 – Inclusion Criteria AB-106 Sensitive : C2
CD74-ROS1 fusion	Non Small Cell Lung Cancer	CD74-ROS1 fusion	Non Small Cell Lung Cancer	crizotinib Sensitive: C3 – Early Trials crizotinib Sensitive : C3	crizotinib Sensitive: C3 – Early Trials crizotinib Sensitive : C3
CD74-ROS1 fusion	Non Small Cell Lung Cancer	CD74-ROS1 fusion	Non Small Cell Lung Cancer	repotrectinib Resistant: C4 – Case Studies repotrectinib Resistant : C4	repotrectinib Resistant: C4 – Case Studies repotrectinib Resistant : C4
CD74-ROS1 fusion	Lung Adenocarcinoma	CD74-ROS1 fusion	Lung Adenocarcinoma	cisplatin + pemetrexed Sensitive: C4 – Case Studies cisplatin + pemetrexed Sensitive : C4	cisplatin + pemetrexed Sensitive: C4 – Case Studies cisplatin + pemetrexed Sensitive : C4
CD74-ROS1 fusion	Lung Adenocarcinoma	CD74-ROS1 fusion	Lung Adenocarcinoma	entrectinib Sensitive: C4 – Case Studies entrectinib Sensitive : C4	entrectinib Sensitive: C4 – Case Studies entrectinib Sensitive : C4
CD74-ROS1 fusion	Malignant Pleural Mesothelioma	CD74-ROS1 fusion	Malignant Pleural Mesothelioma	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4
CD74-ROS1 fusion	Lung Adenocarcinoma	CD74-ROS1 fusion	Lung Adenocarcinoma	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4
CD74-ROS1 fusion	Lung Adenocarcinoma	CD74-ROS1 fusion	Lung Adenocarcinoma	lorlatinib Sensitive: C4 – Case Studies lorlatinib Sensitive : C4	lorlatinib Sensitive: C4 – Case Studies lorlatinib Sensitive : C4
CD74-ROS1 fusion	Lung Adenocarcinoma	CD74-ROS1 fusion	Lung Adenocarcinoma	pemetrexed Sensitive: C4 – Case Studies pemetrexed Sensitive : C4	pemetrexed Sensitive: C4 – Case Studies pemetrexed Sensitive : C4
CD74-ROS1 fusion	Lung Cancer	CD74-ROS1 fusion	Lung Cancer	gilteritinib Sensitive: D – Preclinical gilteritinib Sensitive : D	gilteritinib Sensitive: D – Preclinical gilteritinib Sensitive : D